Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

Recruiting now · Phase 1

Conditions studied: Post-hemorrhagic Hydrocephalus (PHH)

In brief

The purpose of this study is to evaluate the safety and efficacy of ventricular microdosing of indocyanine green (ICG) in order to assess cerebrospinal fluid (CSF) ventricular dynamics and extracranial CSF outflow using fluorescent Cap-based Transcranial Optical Tomography (fCTOT) and Near-InfraRed Fluorescent (NIRF) imaging and to evaluate inflammation markers of the CSF and to correlate with CSF ventricular dynamics, extracranial outflow into the lymphatics, ventriculomegaly, and patient's clinical outcome in order to understand how inflammation may impact that status of extracranial outflow.

Key facts

Study ID
NCT06994949
Run by
Eva Sevick
People needed
20
Starts
2025-01-14
Expected to finish
2029-01-03
Last updated by the study team
2025-05-29

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.